Evidence map›Paper›PMID 41360755›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

CACLENS: A Multitask Deep Learning System for Enzyme Discovery.

Xilong Yi, Yingzhu Tan, Huikang Lin, Guoqing Zhang, Ye Tian, Aibo Wu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. CACLENS: A Multitask Deep Learning System for Enzyme Discovery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xilong YiShanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Yingzhu TanShanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Huikang LinShanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Guoqing ZhangShanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Ye TianShanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Aibo WuShanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.ORCID https://orcid.org/0000-0002-7161-1592

Funding

Key Joint Funds of the National Natural Science Foundation of China U24A20473National Key Research and Development Program of China 2023YFF1104604National Science Fund for Distinguished Young Scholars 32025030Shanghai Agriculture Applied Technology Development Program, China T2023219
6 · The paper itself

Abstract

Deep learning greatly advances large-scale predictions of enzymatic structure, function, and properties. However, existing deep learning models remain limited in high-performance screen of functional enzymes, due to a lack of multimodal learning and multitask prediction capabilities. To address these challenges, CACLENS (Cross-Attention & Contrastive Learning-enabled Enzyme Selection) is introduced, a multitask deep learning framework incorporating Customized Gate Control, contrastive learning, and cross-attention mechanisms. CACLENS demonstrates robust performance across three key functions-reaction type classification, EC number prediction, and reaction feasibility assessment with fewer computational resources. These three functions are seamlessly incorporated into the enzyme screening pipeline for efficient screening of desired enzymes in biosynthesis and biodegradation processes, thereby significantly expediting the discovery of industrial enzymes. Using CACLENS, 10 potential degrading enzymes against Zearalenone (ZEN) are predicted and expressed, and one of them achieves a degradation efficiency of over 90% for ZEN and its analogue α-ZOL. In addition, a user-friendly web server for CACLENS is established and is accessible at https://ai.caclens.com/ for researchers to discover catalytic elements.

Indexed as

Deep LearningEnzymesEnzymesbiodegradationenzyme screeningmultitask deep learningsynthetic biology

Identifiers

PMID41360755
PMCPMC12904076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.